New drug shown to improve bone growth in children with achondroplasia in global phase III trial

A phase three global clinical trial led by the Murdoch Children’s Research Institute (MCRI) has shown a new drug boosts bone growth in children born with achondroplasia, the most common type of dwarfism. The randomized, double-blind, placebo-controlled trial results, led by MCRI clinical geneticist Professor Ravi Savarirayan, have been published […]